Ads
related to: total hip replacement devices recall pdfsodapdf.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson and Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010.
Hip replacement is one of the most common orthopaedic operations, though patient satisfaction varies widely. Approximately 58% of total hip replacements are estimated to last 25 years. The average cost of a total hip replacement in 2012 was $40,364 in the United States, and about $7,700 to $12,000 in most European countries.
The hip resurfacing devices are metal-on-metal articulating devices which differ from total hip replacement devices because they are more bone conserving and retain the natural geometry (so-called large ball THR devices share this trait).
The devices were recalled because of concerns that foam used in them could degrade and become toxic, carrying potential cancer risks. CEO Roy Jakobs declined to say whether the bill was smaller...
Philips was recalling some models of the Panorama 1.0T HFO device in the U.S. due to risk of explosion during a "quench procedure" caused by excessive buildup of helium gas.
On August 24, 2010, DePuy recalled all ASR hip implant systems sold since 2003. The 2010 DePuy Hip Recall was issued after research released by the National Joint Registry (NJR) found high rates of hip replacement failure for the ASR XL Acetabular and ASR Hip Resurfacing systems.
Who might need hip replacement surgery? Porizkova's hip issues were caused by developmental hip dysplasia.
I think that a link should be added at the bottom of the hip replacement page to healthyjoints.com. Healthy Joints is an online support group and informational exchange for people with an interest in hip replacement and other joint problems. It would be a great resource for anyone on the hip replacement page. Here's a link to the site:
On August 24, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%.
Minimally invasive hip resurfacing (MIS) is a total or partial hip surgery that can be carried out through an incision of less than 10 cm (4 inches) without imparting great forces on the anatomy or compromising component positioning.
Ad
related to: total hip replacement devices recall pdf